Alys Pharmaceuticals
Latest round
- Seed
Last raised
- Feb 2024
Total raised
- $100M
Investors
- 1
About Alys Pharmaceuticals
Founded in 2024 and based in Massachusetts, US, Alys Pharmaceuticals, Inc. operates as a provider of science-based treatments for immunodermatology. In February 2024, Alys Pharmaceuticals, Inc. Alys Pharmaceuticals provides a research and development pipeline comprising an active program targeting various dermatologic indications. Through the integration of multiple platform technologies, the company develops therapies that transform the treatment landscape across a spectrum of dermatological conditions, addressing unmet medical needs and improving patient outcomes.
Who invested in Alys Pharmaceuticals
1 investor across 1 round
See all investors in Alys Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 12, 2024
Amount
$100M
Investors
Questions about Alys Pharmaceuticals
Who invested in Alys Pharmaceuticals?
Alys Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alys Pharmaceuticals raised?
Alys Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alys Pharmaceuticals last raise money?
Alys Pharmaceuticals's most recent round on record is a Seed, in Feb 2024.
What does Alys Pharmaceuticals do?
Founded in 2024 and based in Massachusetts, US, Alys Pharmaceuticals, Inc.
Where is Alys Pharmaceuticals headquartered?
Alys Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Alys Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alys Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Alys Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.